Skip to content

Sign in Start free

Create your free account

Loading your page…

We care for the people who care.

No ads. No selling of your data. No third-party trackers.

Apps

Prognia
Ward
Suture
Osler

Library

Guidelines
Medicines
Articles
Calculators
Explore decks
Institutions
Pharmaceutical companies
Blog

Prognia

About
Pricing
Contact

Support us

Founders Wall

© 2026 Prognia · Amsterdam, the NetherlandsPrivacy TermsExchangeRate-API

Loading…

Medicines
Spain
Upadacitinib

AEMPS 2026

Upadacitinib

Rinvoq 30 MG Comprimidos de Liberacion Prolongada

30,7 mg comprimido de liberación prolongadaSpainAuthorisedAuthorised 17 Aug 2026

Product informationAsk Osler about it

On this page

In other countries
Packs
Documents
Sources and licences

In other countries

The same active substances on other registers, the same brand first.

RinvoqBrazil · Abbvie Farmacêutica Ltda.Same brand
RinvoqCanada · 30 MG · Tablet (Extended-Release) · Abbvie CorporationSame brand
RinvoqCanada · 15 MG · Tablet (Extended-Release) · Abbvie CorporationSame brand
RinvoqCanada · 45 MG · Tablet (Extended-Release) · Abbvie CorporationSame brand
RinvoqEuropean Union · AbbVie Deutschland GmbH & Co. KGSame brand
RinvoqCroatiaSame brand
RinvoqItaly · Compressa a rilascio prolungato · Abbvie Deutschland GMBH & Co. KGSame brand
RINVOQ 15 mg tabletten met verlengde afgifte

More with the same substance on this register

Rinvoq 15 MG Comprimidos de Liberacion ProlongadaUpadacitinib · 15,4 mg · comprimido de liberación prolongadaSpain
Rinvoq 30 MG Comprimidos de Liberacion ProlongadaUpadacitinib · 30,7 mg · comprimido de liberación prolongada

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Netherlands · Tablet met verlengde afgifte · AbbVie Deutschland GmbH & Co. KG

Same brand

🇳🇱RINVOQ 30 mg tabletten met verlengde afgifteNetherlands · Tablet met verlengde afgifte · AbbVie Deutschland GmbH & Co. KGSame brand

🇳🇱RINVOQ 45 mg tabletten met verlengde afgifteNetherlands · Tablet met verlengde afgifte · AbbVie Deutschland GmbH & Co. KGSame brand

🇳🇿RinvoqNew Zealand · Tab modified-release 30 mgSame brand

🇳🇿RinvoqNew Zealand · Tab modified-release 15 mgSame brand

🇳🇿RinvoqNew Zealand · Tab modified-release 45 mgSame brand

🇷🇴RINVOQ 15mgRomania · 15mg · compr. elib. prel. · Abbvie Deutschland GMBH &Co.KGSame brand

🇷🇸Rinvoq®Serbia · 30mg · tableta sa produženim oslobađanjem · Abbvie D.O.O. BeogradSame brand

🇷🇸Rinvoq®Serbia · 30mg · tableta sa produženim oslobađanjem · Abbvie D.O.O. BeogradSame brand

🇷🇸Rinvoq®Serbia · 45mg · tableta sa produženim oslobađanjem · Abbvie D.O.O. BeogradSame brand

🇸🇦RinvoqSaudi Arabia · Abbvie Ireland NL B.V.Same brand

🇸🇦RinvoqSaudi Arabia · AbbVie IrelandSame brand

🇸🇦RinvoqSaudi Arabia · AbbVie IrelandSame brand

🇸🇬Rinvoq Extended-Release Tablet 15MGSingapore · 15mg · tablet, film coated, extended release · Abbvie Pte. LTD.Same brand

🇸🇬Rinvoq Extended-Release Tablet 30MGSingapore · 30mg · tablet, film coated, extended release · Abbvie Pte. LTD.Same brand

🇸🇬Rinvoq Extended-Release Tablet 45MGSingapore · 45mg · tablet, film coated, extended release · Abbvie Pte. LTD.Same brand

🇺🇸RinvoqUnited States · 15MG, 30MG, 45MG · tablet, extended release · AbbvieSame brand

🇺🇸Rinvoq LQUnited States · 1MG/ML · solution · AbbvieSame brand

🇺🇸UpadacitinibUnited States · 15MG, 30MG · tablet · Aurobindo Pharma LTDSame form

Packs

Pack	Code	Status
RINVOQ 30 MG COMPRIMIDOS DE LIBERACION PROLONGADA, 28 comprimidos	771735

Documents

The official texts, at the regulator.

Summary of product characteristicsAEMPS
Package leafletAEMPS
Register entryAEMPS

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Upadacitinib
Strength: 30,7 mg
Dosage form: comprimido de liberación prolongada
Route: vía oral
Register: Spain (AEMPS)
Status: Authorised
Status in the register: Autorizado, no comercializado
Authorised: 17 Aug 2026
Registration: 1191404006IP
Marketing authorisation holder: Abbvie Deutschland Gmbh & Co. Kg
Procedure: EU centralised
Supply: Diagnóstico Hospitalario

🇪🇸Spain

AEMPSRinvoq 45 MG Comprimidos de Liberacion ProlongadaUpadacitinib · 46,1 mg · comprimido de liberación prolongada🇪🇸Spain

AEMPSRinvoq 1MG/ML Solucion OralUpadacitinib · 1,02 mg · solución oral🇪🇸Spain